Clinical Trials Logo

Clinical Trial Summary

Cognitive impairment affects up to 65% of multiple sclerosis (MS) subjects, especially memory function.

Rothschild Foundation has developped the Paris Visual Learning and memory Test (PVLT). 165 healthy volunteers were studied for its normalization.

The main objective of the present study is to assess the validity of PVLT by comparing MS patients' test results to a database including the test results of 280 healthy control subjects, following recommended international standards.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02893683
Study type Observational
Source Fondation Ophtalmologique Adolphe de Rothschild
Contact
Status Completed
Phase N/A
Start date December 19, 2013
Completion date May 15, 2017

See also
  Status Clinical Trial Phase
Active, not recruiting NCT02486640 - Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon
Active, not recruiting NCT02835677 - Integrating Caregiver Support Into MS Care N/A
Not yet recruiting NCT03550170 - Fatigue Management Programs for People With MS N/A
Recruiting NCT03269175 - BENEFIT 15 Long-term Follow-up Study of the BENEFIT and BENEFIT Follow-up Studies Phase 4
Recruiting NCT02845635 - MS Mosaic: A Longitudinal Research Study on Multiple Sclerosis
Recruiting NCT02232061 - Long-term, Open-label, Multicenter Study Assessing Long-term Cardiovascular Risks in Patients Treated With Fingolimod Phase 4
Recruiting NCT03222973 - Efficacy and Safety of BIIB033 (Opicinumab) as an Add-on Therapy to Disease-Modifying Therapies (DMTs) in Relapsing Multiple Sclerosis (MS) Phase 2
Recruiting NCT03424733 - Evaluating the Use of Prednisone to Decrease Pegylated Interferon Beta-1a Side Effects Phase 4
Recruiting NCT03326505 - Allogenic Mesenchymal Stem Cells And Physical Therapy for MS Treatment Phase 1/Phase 2
Recruiting NCT03122652 - Multi-center, Interventional, Phase 3, Randomized, Double-blinded Study of Treatment:Teriflunomide®, in Radiologically Isolated Syndrome Phase 3
Recruiting NCT02939859 - Use of Cellular Stromal Vascular Fraction in Multiple Sclerosis,Autoimmune, Inflammatory, Neurologic Conditions N/A
Completed NCT02898974 - Medical Marijuana and Its Effects on Motor Function in People With Multiple Sclerosis N/A
Recruiting NCT02283671 - Treatment of Multiple Sclerosis and Neuromyelitis Optica With Regulatory Dendritic Cell: Clinical Trial Phase 1 B Phase 1
Active, not recruiting NCT02522962 - Innovative Physiotherapy and Coordination of Care for People With MS: a RCT and a Qualitative Study N/A
Completed NCT02571335 - Impacts of Different Training Modes (Intense Versus Ordinary) on the Immune System and Memory Functions in pwMS N/A
Not yet recruiting NCT01954823 - Use of an Electronic Diary by People With Multiple Sclerosis N/A
Recruiting NCT02282878 - The Effect of Dietary Salt Intake on Immune Function in Patients With Multiple Sclerosis N/A
Recruiting NCT02538094 - tDCS and Cognition in Adults With Multiple Sclerosis or Encephalitis N/A
Recruiting NCT02777060 - Exploring the Effectiveness of Sensor-based Balance Training on Patient Outcome Measures N/A
Recruiting NCT03541226 - Clinical Monitoring, MRI and Neuro-Ophthalmology of a Cohort of Patients With a Clinically Isolated Syndrome (CIS)